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Abstract
The Surviving Sepsis Guidelines can serve as a structure to help educate and create a set of recommendations on how to
care for patients through this complicated pathway of shock. Designing a cardiogenic shock bundle could reduce the variability
of care and possibly improve survival. Also, a more standard protocol would allow a review of the outcomes and a system to
change practice nationally when new data or technology becomes available. This could create a continuous quality
improvement cycle. Creating a “Surviving Cardiogenic Shock” system could help provide awareness for recognition of
cardiogenic shock and advanced management alternatives needed at level one and two hospitals. The creation of cardiogenic
shock systems of care would support smaller hospitals with a Hub and Spoke structure. Cardiogenic shock is not septic shock,
but those in cardiology and cardiac critical care can and should take lessons from the Surviving Sepsis Campaign.
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Background

the EPIC electronic health record system has the MEWS
already built in.

The Surviving Sepsis Campaign is an international set of
guidelines for the management of sepsis and septic shock. It
provides guidance on the care of hospitalized adult patients
with, or at risk of, sepsis. The goals are early identification and
appropriate management in the initial hours after the
development of sepsis to improve outcomes. To achieve that
goal, sepsis bundles are used to improve program performance
by integrating sepsis scoring, education, metrics, and patient
outcomes. Meta-analysis and clinical trials have shown that
using sepsis bundles improves mortality rates for patients with
sepsis and septic shock. All bundles use sepsis screening tools,
and the debate continues about which one is best for each
situation. The most common include the quick sequential
organ failure assessment (qSOFA), modified sequential organ
failure assessment (mSOFA), national early warning score
(NEWS), and modified early warning score (MEWS). Indeed,

Recommendations
First published in 2004,1 the guidelines put forth by the
Surviving Sepsis Campaign have had several revisions, with
the most recent being at the end of 2021.2 Most recently, over
20
recommendations
have
been
updated.
One
recommendation supports the use of the SOFA score over
MEWS or NEWS. Another recommendation is to give
crystalloid (30 mL/kg) to patients with hypoperfusion or
shock within 3 hours. There is also a recommendation to use
dynamic measures to guide fluid resuscitation over physical
examination or static parameters. A suggestion for this is to
use capillary refill as a guide for resuscitation. However, the
new guidelines do not emphasize measuring central venous
pressure; they do recommend looking at volume loading
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through some of those techniques. A mean arterial pressure of
65 mmHg is the recommended target pressure. The reality,
though, is that there are not a lot of hemodynamic parameters
included in the recommended sepsis bundle.

Cardiogenic Shock vs Septic Shock
While cardiogenic shock is not septic shock, the guidelines
for septic shock do inform care. Sepsis has a relatively
common etiology, including infection or inflammation. It has
low-tech initial therapies that include intravenous (IV) fluids,
IV antibiotics, IV vasopressors, and basic hemodynamic
monitoring such as heart rate, blood pressure, and
electrocardiogram. All therapies are available in acute care
hospitals. Alternatively, cardiogenic shock has various
etiologies and phenotypes that make the initial therapy
variable as well. Treatment of cardiogenic shock involves
advanced therapies that are not cheap and are not available in
all hospitals.
The goal of the septic bundles is to cut down on
variations, which is helpful for escalation and de-escalation.
Thus, can a bundle be adapted to help inform cardiogenic
shock therapy and reduce the huge variability in practice?

Critical Care Cardiology Trials
Clinical registries, such as the Critical Care Cardiology
Trials Network (CCCTN), have looked at variations in care in
the management of cardiogenic shock. This includes the use
of pulmonary artery (PA) catheters to assess and guide
management, acute mechanical circulatory support devices
such as the intra-aortic balloon pump (IABP), and the Impella
percutaneous ventricular assist device (pVAD) (Abiomed).
Utilization of the IABP in all care centers, tertiary or
quaternary, varied and was dependent upon whether a shock
team was present or not.3,4 The presence of a shock team
correlated with less IABP use and more Impella implantations.
One of the key issues is that only 42% of patients who had
advanced circulatory support and Impella or extracorporeal
membrane oxygenation (ECMO) had a PA catheter placed. In
the CCCTN registry, the use of a PA catheter was associated
with improved survival. However, the use of PA catheters
varied significantly among the different centers. This may be
in part due to the perceived risk associated with use and cost.
Surprisingly, many of the patients who received advanced
mechanical circulatory support did not have PA catheter
monitoring. While there are currently no randomized clinical
trials demonstrating that PA catheters improve outcomes in
conjunction with AMCS, current registries such as the
CCCTN and the National Cardiogenic Shock registries
demonstrate a strong correlation with survival in cardiogenic
shock when a PA catheter is utilized to guide care. While there
is literature on protocols for the management of cardiogenic
shock and shock teams, there currently is no national
consensus, similar to the Surviving Sepsis Bundles. It is likely
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that a consensus of best practice guidelines for the
management of cardiogenic shock or care bundles may allow
for a structure to further improve outcomes.

Conclusion
The Surviving Sepsis Guidelines can serve as a structure
to help educate and create a set of recommendations on how
to care for patients through this complicated pathway of shock.
Designing a cardiogenic shock bundle could reduce the
variability of care and possibly improve survival. Also, a more
standard protocol would allow a review of the outcomes and a
system to change practice nationally when new data or new
technology becomes available. This could create a continuous
quality improvement cycle. Creating a “Surviving
Cardiogenic Shock” system could help provide awareness for
recognition of cardiogenic shock and advanced management
alternatives needed at level one and two hospitals. The
creation of cardiogenic shock systems of care would support
smaller hospitals with a Hub and Spoke structure. Cardiogenic
shock is not septic shock, but those in cardiology and cardiac
critical care can and should take lessons from the Surviving
Sepsis Campaign.
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